ICON is a global provider of outsourced drug development services to biopharma, medical device, government, biosimilar and generic organisations.
We offer a full range of clinical, consulting and commercial services that range from trial design to full study execution, and from clinical to post-market commercialisation.
Our services are supported by in-depth therapeutic and regulatory expertise and market-leading technology and analytics. We are the only full service CRO that offers the knowledge, software and systems for adaptive trials.
Read the white paper to discover why an integrated operational framework is key to efficient data management.
Three key pillars include risk based quality management systems, increased oversight and technology validation and certification.
Webinar: 7th June, 2017
Learn best practices for developing early economic models to inform key strategic decisions.